Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development

Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development

The hyperphosphorylation of tau protein and the overexpression of mTOR are considered to be the driving force behind Aβ plaques and Neurofibrillay Tangles (NFT's), hallmarks of Alzheimer's disease (AD). It is now evident that miscellaneous diseases such as Diabetes, Autoimmune diseases, Ca...

Full description

Bibliographic Details
Main Authors:	Zeba Mueed, Pallavi Tandon, Sanjeev Kumar Maurya, Ravi Deval, Mohammad A. Kamal, Nitesh Kumar Poddar
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-01-01
Series:	Frontiers in Neuroscience
Subjects:	Alzheimer's disease (AD) tau mTOR Aβ plaques Aβ modulators hyperphosphorylation
Online Access:	https://www.frontiersin.org/article/10.3389/fnins.2018.01017/full

Similar Items

Morin attenuates tau hyperphosphorylation by inhibiting GSK3β
by: Eun Ji Gong, et al.
Published: (2011-11-01)

Berberine Reduces Aβ42 Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress
by: Yue Wu, et al.
Published: (2021-07-01)

Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures
by: Carolyn A. Rankin, et al.
Published: (2008-09-01)

Curcuminoids and resveratrol as anti-Alzheimer agents
by: Oliver B. Villaflores, et al.
Published: (2012-12-01)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
by: Yan Zhou, et al.
Published: (2018-02-01)

Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies
by: Qiuchen Zheng, et al.
Published: (2019-06-01)

Silencing I2PP2A rescues tau pathologies and memory deficits through rescuing PP2A and inhibiting GSK-3β signaling in human tau transgenic mice
by: Yao eZhang, et al.
Published: (2014-06-01)

Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability
by: Alejandra D. Alonso, et al.
Published: (2018-10-01)

Investigations into Tyrosine-mediated Hyperphosphorylation and Aggregation of Tau Protein via Ferrocene Bioconjugates
by: Rains, Meghan Krystyna
Published: (2012)

Investigations into Tyrosine-mediated Hyperphosphorylation and Aggregation of Tau Protein via Ferrocene Bioconjugates
by: Rains, Meghan Krystyna
Published: (2012)

Spirulina platensis alleviates high fat diet-induced cognitive impairment in mice via the gut-brain axis
by: Tao Zhou, et al.
Published: (2021-11-01)

Eicosapentaenoic acid-enriched phospholipids improve Aβ1–40-induced cognitive deficiency in a rat model of Alzheimer's disease
by: Min Wen, et al.
Published: (2016-06-01)

Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes
by: M.A Kurt, et al.
Published: (2003-10-01)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
by: Jin Miao, et al.
Published: (2019-03-01)

Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology
by: Antoine Duquette, et al.
Published: (2021-01-01)

Targeting Tau to Treat Clinical Features of Huntington's Disease
by: Maria Masnata, et al.
Published: (2020-11-01)

Hyperphosphorylation-induced tau oligomers
by: Khalid eIqbal, et al.
Published: (2013-08-01)

Neurons Expressing Pathological Tau Protein Trigger Dramatic Changes in Microglial Morphology and Dynamics
by: Rahma Hassan-Abdi, et al.
Published: (2019-11-01)

Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy
by: Seyedeh Maryam Alavi Naini, et al.
Published: (2018-03-01)

Current anti-Alzheimer’s disease effect of natural products and their principal targets
by: Ye Zhu, Le Peng, Jian Hu, Yan Chen, Faxiu Chen
Published: (2019-09-01)

Air pollution & the brain: Subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease
by: McDonald Jacob, et al.
Published: (2011-08-01)

GSK3β-mediated tau hyperphosphorylation triggers diabetic retinal neurodegeneration by disrupting synaptic and mitochondrial functions
by: Huazhang Zhu, et al.
Published: (2018-11-01)

SET SUMOylation promotes its cytoplasmic retention and induces tau pathology and cognitive impairments
by: Min Qin, et al.
Published: (2019-02-01)

DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders
by: Ravindran Kumaran, et al.
Published: (2007-10-01)

Neuroprotective effects of tenuigenin on neurobehavior, oxidative stress, and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats
by: Xiao-Bo Huang, et al.
Published: (2018-01-01)

Astaxanthin Ameliorated Parvalbumin-Positive Neuron Deficits and Alzheimer’s Disease-Related Pathological Progression in the Hippocampus of AppNL-G-F/NL-G-F Mice
by: Nobuko Hongo, et al.
Published: (2020-03-01)

Tau Pathology in Parkinson's Disease
by: Xue Zhang, et al.
Published: (2018-10-01)

Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation
by: Anna Ochalek, et al.
Published: (2017-12-01)

Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells
by: Yao K, et al.
Published: (2019-01-01)

Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models
by: Nigel C. Jones, et al.
Published: (2012-03-01)

Hyperphosphorylation of Tau Protein in Hippocampus of Central Insulin-Resistant Rats is Associated with Cognitive Impairment
by: Dantao Peng, et al.
Published: (2013-11-01)

Structure Based Design and Molecular Docking Studies for Phosphorylated Tau Inhibitors in Alzheimer’s Disease
by: Jangampalli Adi Pradeepkiran, et al.
Published: (2019-03-01)

Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice
by: Fiona Grueninger, et al.
Published: (2010-02-01)

Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain
by: Jan R. Detrez, et al.
Published: (2019-07-01)

Epigallocatechin-3-Gallate Provides Protection Against Alzheimer’s Disease-Induced Learning and Memory Impairments in Rats
by: Nan S, et al.
Published: (2021-05-01)

Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice
by: Céline Héraud, et al.
Published: (2014-02-01)

Microglia in Alzheimer’s Disease in the Context of Tau Pathology
by: Juan Ramón Perea, et al.
Published: (2020-10-01)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
by: Yam Nath Paudel, et al.
Published: (2020-06-01)

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
by: Kok Pin Ng, et al.
Published: (2021-03-01)

Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
by: Fuyuki Kametani, et al.
Published: (2018-01-01)